Escolar Documentos
Profissional Documentos
Cultura Documentos
http://www.who.int/bulletin/volumes/92/1/13-124495/en/.
Akses tanggal Agustus 2015.
Franklin SS, (2001). Epidemiology of Hypertensive Cardiovascular Risk. Diakses
melalui:
https://www.acponline.org/atpro/timssnet/images/books/sample
%20chapters/Hypertension_Ch02.pdf [Diakses pada 2 Juli 2015].
Fuster V, Richard Walsh, Robert Harrington, (2011). Systemic Arterial Hypertension.
Dalam: Hursts The Heart Ed. 13th. China: McGraw-Hill Companies Inc.
Chapter 68
Gaziano TA, Gaziano JM, (2010). Epidemiology of Cardiovascular Disease. Dalam
Harrisons Cardiovascular Medicine. The McGraw-Hill Companies, Inc.
Section 1, part 2, page 18.
Grossman E, Franz M, (2008). Hypertension and Diabetes. Fisman EZ, Tenenbaum A
(eds): Cardiovascular Diabetology: Clinical, Metabolic and Inflammatory
Facets. Adv Cardiol. Basel, Karger, 2008, vol 45, pp 82106.
Guyton and Hall, (2007). Buku Ajar Fisiologi Kedokteran, Edisi 11. Jakarta: EGC,
hlm 262, 891.
Halperin R, Howard DS, Jing M, Julie B, Meir JS, Michael G, (2006). Dyslipidemia
and the Risk of Incident Hypertension in Men. http://hyper.ahajou4rn5als.org/.
Akses tanggal Januari 2016.
Harper Kristin, George Armelagos, (2010). The Changing DiseaseScape in the Third Epidemiological Transition. Int J Environ Res
Public Health. 7(2): 67597.
Ikeda N, David S, Ramiro G, Wichai A, Mohsen N, Ali H. M, et al., (2014). Control
of Hypertension With Medication: a Comparative Analysis of National
Surveys In 20 Countries. Bull World Health Organ; 92:1019C.
Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW et al.,
(2012). American Association of Clinical Endocrinologists Guidelines for
Management of Dyslipidemia and Prevention of Atherosclerosis. American
Association of Clinical Endocrinologists (AACE), Endocrine Practice Vol 18,
page 3.
Jones JDM, Eric P. Leip, Martin G. Larson, Ramachandran S. Vasan, dan Daniel
Levy (2005). Novel Approach to Examining First Cardiovascular EventsAfter
Hypertension Onset. American Heart Association. January, Vol. 45, page: 3945.
Klag MJ, (2012). Epidemiology of Cardiovascular Disease. Dalam Lee Goldman dan
Andrew I. Schafer (eds). Goldmans Cecil Medicine, 24th Edition.
Philadelphia: Elsevier Saunders, page 256-7.
Leone A, (2015). Smoking and Hypertension. J Cardiol Curr Res. Volume 2, Issue 2.
Page 2
Lewin A, Henry P, Xiaohui L, Manfred S, (2013). Nebivolol Monotherapy for
Patients With Systolic Stage II Hypertension: Results of a Randomized,
Placebo-Controlled Trial. Elsevier HS Journals, Inc. Volume 35, Number 2.
Page 142-3.
Libby P, Jordan B. Strom, (2011). Atherosclerosis. In Lilly (eds). Pathophysiology of
Heart Disease, 5th Edition. Philadelphia: Lippincot Williams & Wilkins, page
113-31.
Murphy JG and Lloyd MA, (2007). Mayo Clinic Cardiology, 3rdEdition. Mayo Clinic
Scientific Press, page 687-741.
Nababan, D. (2008). Hubungan Faktor Risiko dan Karakteristik Penderita dengan
Kejadian Penyakit Jantung Koroner di RSU Dr. Pringadi Medan tahun 2008.
Medan, Sumatera Utara, Universitas Sumatera Utara Medan. Tesis.
National Diabetes Education Program (NDEP) (2014). The Link Between Diabetes
and Cardiovascular Disease. http://ndep.nih.gov/media/CVD_FactSheet.pdf.
Diakses Juni 2014.
North East Valley Division of General Practice (NEVDGP) (2015). Prevention of
Long Term Complication. http://nevdgp.org.au/info/diabetes/d_ltcomp.htm.
Diakses 15 Desember 2015.
Oparil S, M.Amin Zaman, David A. Calhoun, (2003). Pathogenesis of Hypertension.
Physiology In Medicine: A Series Of Articles Linking Medicine With Science.
Volume 139: 769
Pepine CJ, Drexter H, Dzau VJ, (1996). Endothelial Cell in Cardiovascular Health
and Disease. Florida:University of Florida.
Pereira Telmo, (2012). Dyslipidemia and Cardiovascular Risk: Lipid Ratios as Risk
Factors for Cardiovascular Disease, Dyslipidemia - From Prevention to
Treatment, Prof. Roya Kelishadi (Ed.), ISBN: 978-953-307-904-2, InTech,
Available
from:
http://www.intechopen.com/books/dyslipidemia-fromprevention-totreatment/ dyslipidemia-and-cardiovascular-risk-lipid-ratios-asrisk-factors-for-cardiovascular-disease
Phibbs B, (2007). Blood Supply of the heart. In: Human Heart, The: A Basic Guide to
Heart Disease.. 2nd Edition. Lippincott Williams & Wilkins, chapter 4.
Ridker Paul M, Peter Libby, Julie E. Buring, (2015). Risk Markers and the Primary
Prevention of Cardiovascular Disease. In Braunwalds Heart Disease, 10th
Edition. Philadelphia: Elsevier, page 895.
Sadeghi R, Nadia A, Azam E, Latif G, Zohre M, (2013). Premature Coronary Heart
Disease and Traditional Risk Factors-Can We Do Better? Int Cardiovasc Res
J.2013;7(2):46-50.
Sayeed, M.A., H. Mahtab, S. Sayeed, T. Begum, P.A. Khanam, dan A. Banu. (2010).
Prevalence and Risk Factors of Coronary Heart Disease in Rural Population
of Bangladesh. Journal of Ibrahim Med. Coll. 4(2): 37-43.
Shahab A (2007). Komplikasi kronik DM penyakit jantung koroner. Dalam: Sudoyo
AW, Setiyohadi B, Alwi I, Simadibrata KM, Setiati S, (eds). Buku Ajar Ilmu
Penyakit Dalam Jilid III. Edisi ke-4. Jakarta: Departemen Ilmu Penyakit
Dalam FKUI; 2007. hlm. 1894-6.
Shireman PK, Pearce WH, (1996). Endothelial Cell Function: Biologic and
Physiologic Functions In Health And Disease. AJR Am J Roentgenol; 166: 713.
Smith DG, (2007). Epidemiology of Dyslipidemia and Economic
Burden
on
the
HealthcareSystem.
http://www.ajmc.com/publications/supplement/2007/2007-06vol13-n3Suppl/Jun07-2502pS69-S71/ . Diakses April 2014.
Smoking, the Heart and Circulation, (2013). ASH Fact Sheet on
smoking,
the
heart
and
circulation.
Diunduh
dari
http://ash.org.uk/files/documents/ASH_111. Diakses Januari
2016.